Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00203255
Status:
COMPLETED
Last Update Posted:
2009-01-23
First Post:
2005-09-13
Brief Title:
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
Sponsor:
Thomas Jefferson University
Organization:
Thomas Jefferson University
Study Overview
Official Title:
An Open-Label Pilot Study Examining the Use of Soy Isoflavones in the Prevention of Menstrually-Associated Migraine
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to study the use of soy isoflavones in the prevention of menstrually-associated migraines Additionally this trial may provide insight into the menstrual cycle and menstrually-related headaches in women With this information we may be able to change current treatment methods or even develop new methods in order to advance current approaches in the treatment of menstrual migraine
Detailed Description:
Many women have increased headache attacks at the time of their period menses The migraines experienced around the menstrual cycle are most often associated with premenstrual complaints such as nausea backache and breast tenderness The condition of hormone-related headache ie menstrual migraine is unclear
Soy isoflavones have been used to alleviate the symptoms of menopause They contain natural estrogens female hormones Since menstrual migraine is thought to be associated with the withdrawal of estrogen or the natural fall of estrogen levels the use of this natural source of estrogen may be helpful in the prevention of menstrually-associated migraine
Soy isoflavones have been used to alleviate the symptoms of menopause They contain natural estrogens female hormones Since menstrual migraine is thought to be associated with the withdrawal of estrogen or the natural fall of estrogen levels the use of this natural source of estrogen may be helpful in the prevention of menstrually-associated migraine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None